000 | 01714 a2200457 4500 | ||
---|---|---|---|
005 | 20250513031809.0 | ||
264 | 0 | _c19950815 | |
008 | 199508s 0 0 eng d | ||
022 | _a0009-2797 | ||
024 | 7 |
_a10.1016/0009-2797(94)03603-6 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aLi, S J | |
245 | 0 | 0 |
_aThe activity of xenobiotic enzymes and the cytotoxicity of mitoxantrone in MCF 7 human breast cancer cells treated with inducing agents. _h[electronic resource] |
260 |
_bChemico-biological interactions _cJul 1995 |
||
300 |
_a101-18 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 |
_aBenz(a)Anthracenes _xpharmacology |
650 | 0 | 4 |
_aBreast Neoplasms _xdrug therapy |
650 | 0 | 4 |
_aCell Death _xdrug effects |
650 | 0 | 4 |
_aCytochrome P-450 Enzyme System _xmetabolism |
650 | 0 | 4 |
_aDexamethasone _xpharmacology |
650 | 0 | 4 |
_aDicumarol _xpharmacology |
650 | 0 | 4 | _aEnzyme Induction |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aGlutathione _xmetabolism |
650 | 0 | 4 |
_aGlutathione Peroxidase _xmetabolism |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aL-Lactate Dehydrogenase _xmetabolism |
650 | 0 | 4 |
_aMetyrapone _xpharmacology |
650 | 0 | 4 |
_aMitoxantrone _xtherapeutic use |
650 | 0 | 4 |
_aNAD(P)H Dehydrogenase (Quinone) _xmetabolism |
650 | 0 | 4 |
_aNADPH-Ferrihemoprotein Reductase _xmetabolism |
650 | 0 | 4 |
_aPhenobarbital _xpharmacology |
650 | 0 | 4 |
_aRifampin _xpharmacology |
650 | 0 | 4 | _aTumor Cells, Cultured |
650 | 0 | 4 |
_aXenobiotics _xmetabolism |
700 | 1 | _aRodgers, E H | |
700 | 1 | _aGrant, M H | |
773 | 0 |
_tChemico-biological interactions _gvol. 97 _gno. 2 _gp. 101-18 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/0009-2797(94)03603-6 _zAvailable from publisher's website |
999 |
_c7541188 _d7541188 |